Lansdowne Partners

AMNIS Treasury Services AG operates an online platform designed to streamline currency transactions for small and medium-sized enterprises. Founded in 2014 and headquartered in Zurich, Switzerland, the company provides a range of services, including international payments, currency exchange, and risk management. Its platform facilitates local payments and collections across various regions, including the UK, US, Switzerland, and the EU, while offering multi-currency debit cards to simplify expense management. Additionally, AMNIS Treasury Services provides 24/7 currency exchange at transparent rates and offers interest on safeguarded accounts in multiple currencies, such as EUR, USD, GBP, and CZK.

Nattergal operates as a nature restoration company.

G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. The company specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses responsible for colds and flu infections. Its primary product, a targeted therapy utilizing 2-deoxyglucose, disrupts the metabolic processes of host cells, thereby hindering viral replication both in vitro and in vivo, particularly against rhinovirus. By employing a novel host cell-based strategy, G.ST Antivirals aims to create broad-spectrum antiviral treatments that address unmet medical needs in the management of respiratory tract infections.

Oxford Quantum Circuits specializes in quantum computing technology that aims to address significant global challenges, such as climate change and drug discovery. The company has developed a fully functional quantum computer that integrates control systems, hardware, and software, enabling customers to streamline operations and explore innovative solutions. Their unique superconducting circuits are designed to maintain high qubit quality and control, which is essential for achieving commercially viable processing power. By leveraging this advanced technology, Oxford Quantum Circuits supports a range of applications, from pioneering new battery technologies to facilitating life-changing discoveries in medicine.

TechMet Limited is a private industrial company based in Dublin, Ireland, established in 2017. It focuses on securing the supply of key technology metals essential for advanced technologies, including electric vehicles, renewable energy systems, and energy storage devices. The company engages in various stages of the metal supply chain, encompassing mining, processing, refining, and recycling. TechMet's portfolio includes interests in production and development assets located in Africa, North America, and South America. By addressing supply chain challenges associated with critical metals such as nickel, cobalt, lithium, rare earth metals, vanadium, tungsten, and tin, TechMet aims to ensure a stable and sustainable supply that supports the growing demand from emerging technologies.

Crux Asset Management is an asset management firm that offers a range of investment services to clients in Asia, Europe, and the United Kingdom. The company is dedicated to delivering superior investment returns and exceptional client service through a team of highly experienced professionals. Crux specializes in managing long-only equity investments and provides opportunity funds, allowing clients to capitalize on growth potential. By focusing on both the management of its business and the funds it oversees, Crux Asset Management aims to meet the diverse needs of its clientele while fostering robust earnings.

Tungsten West plc operates the historical Hemerdon tungsten and tin mine, located near Plymouth in Devon, England. The mine has a compliant mineral resource of approximately 325 million tonnes, with a grade of 0.12 percent WO3. As demand for strategic metals like tungsten and tin continues to rise due to their essential role in new technologies, Tungsten West aims to meet this demand by restarting production at Hemerdon within the next year. The company benefits from existing infrastructure, which allows for a low-cost production restart, enhancing its position in the market.

Oxford Ionics is a quantum computing startup focused on advancing the development of reliable quantum computers through its innovative use of trapped-ion technology. By combining high-performance qubits with noiseless electronic qubit control, the company offers solutions that allow for precise manipulation of qubits with minimal noise. This technology supports the creation of scalable quantum chips using standard semiconductor fabrication methods, which enhances efficiency and facilitates significant progress in the quantum computing market. Clients benefit from improved computational capabilities, enabling them to tackle complex problem-solving tasks more effectively.

Osler Diagnostics is a UK-based company focused on providing accessible health diagnostics. Established in 2017 from research at the University of Oxford, Osler has developed the Osler Origin, a portable laboratory capable of delivering lab-quality diagnostics anywhere, anytime. This innovative device requires only a drop of blood to test for a wide range of biomarkers, allowing users to monitor various health markers conveniently. Osler aims to serve diverse healthcare settings globally, empowering individuals to understand and manage their health more effectively. The company is headquartered in Oxford, UK.

Replay is a genome writing company focused on advancing genomic medicine by reprogramming biological systems through the synthesis and delivery of large DNA sequences. By innovating in the field of genetic engineering, Replay seeks to redefine the possibilities of genome manipulation and its applications in various medical and therapeutic contexts. Their work aims to facilitate breakthroughs in how genes can be utilized to treat diseases and enhance biological functions, positioning them at the forefront of the evolving landscape of genetic technology.

Circ is a textile recycling company based in Danville, Virginia, focused on recovering value from discarded clothing and textiles. Established in 2011, Circ employs proprietary technology to transform polycotton waste back into its original raw materials, including petroleum- and plant-based fabrics. The company aims to meet growing consumer demands for sustainability without sacrificing quality, price, or convenience. By using water as a solvent, Circ efficiently recycles various fibers, such as cotton, polyester, and nylon, and produces virgin-equivalent, market-grade dissolving pulp and petroleum monomers. These materials can be sold to manufacturers at competitive prices, promoting a circular economy in the textile industry and supporting sustainable living practices.

Oxford Quantum Circuits specializes in quantum computing technology that aims to address significant global challenges, such as climate change and drug discovery. The company has developed a fully functional quantum computer that integrates control systems, hardware, and software, enabling customers to streamline operations and explore innovative solutions. Their unique superconducting circuits are designed to maintain high qubit quality and control, which is essential for achieving commercially viable processing power. By leveraging this advanced technology, Oxford Quantum Circuits supports a range of applications, from pioneering new battery technologies to facilitating life-changing discoveries in medicine.

AMNIS Treasury Services AG operates an online platform designed to streamline currency transactions for small and medium-sized enterprises. Founded in 2014 and headquartered in Zurich, Switzerland, the company provides a range of services, including international payments, currency exchange, and risk management. Its platform facilitates local payments and collections across various regions, including the UK, US, Switzerland, and the EU, while offering multi-currency debit cards to simplify expense management. Additionally, AMNIS Treasury Services provides 24/7 currency exchange at transparent rates and offers interest on safeguarded accounts in multiple currencies, such as EUR, USD, GBP, and CZK.

OXECO is a chemistry technology firm specializing in the creation and manufacture of specialty chemicals for the clean technology and transportation industries. The company employs advanced carbene technology through its innovative ONTOTM platform, which allows for precise control over surface behavior. OXECO provides a range of surface treatment chemicals, including practical surface treatments, chemical insertions, and coatings that are both hydrophobic and hydrophilic. This enables clients to effectively modify and enhance the performance of surfaces in various applications.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was incorporated in 2017. It was spun out from the University of Oxford and focuses on developing innovative agricultural technologies aimed at enabling farmers to produce healthy food through sustainable crop systems. The company leverages research led by Professor Liam Dolan to discover new methods that enhance agricultural productivity while promoting sustainability.

Verve Events is a prominent player in the live entertainment industry, specializing in word-of-mouth sales. The company leverages networks of advocates to promote and sell events and experiences, incentivizing these advocates with rewards such as free tickets and backstage passes. Trusted by more than 500 events globally across over 40 countries, Verve effectively enhances event visibility and attendance through its unique marketing approach. The company collaborates with major ticketing platforms like Ticketmaster, Eventbrite, Paylogic, and Front Gate Tickets to streamline the sales process and enhance customer engagement.

Papier Limited is a London-based company that specializes in designing and printing customized cards and stationery. Established in 2015, the company offers a diverse range of products, including birthday, thank you, sympathy, and seasonal cards, as well as invitations for weddings, parties, and other occasions. Additionally, Papier provides notebooks, planners, and notecards. With an emphasis on quality designs and premium paper, the company aims to inspire meaningful connections through beautifully crafted printed materials, appealing to consumers who appreciate tangible forms of communication amidst a digital landscape. Papier operates digital printing studios to facilitate its offerings and stands out in the online card and invitation market with its curated collection and commitment to artistry.

FINABRO GmbH, founded in 2016 and based in Vienna, Austria, specializes in online financial advice focused on personal savings and investments. The company provides a web-based platform that allows customers to create personalized savings plans and invest their funds effectively. Its services include asset management with a focus on active risk management, enabling clients to navigate the complexities of modern investing. By addressing the challenges of low-interest savings accounts and the risks associated with alternative investment options, FINABRO aims to offer a transparent and cost-effective solution for individuals seeking to optimize their savings and investment strategies. The platform emphasizes tax-efficient investment options and aims to help users achieve higher returns with lower risk through accessible pension plans.

Ribbon Biolabs GmbH, founded in 2018 and based in Vienna, Austria, specializes in the synthesis of long deoxyribonucleic acid (DNA) molecules. The company employs innovative techniques to produce DNA of unprecedented lengths, setting new standards in molecular biology. Its services cater to the diverse needs of synthetic biology, supporting researchers and companies in various applications, including genome construction, high-throughput library creation, and the development of DNA-based products and nanotechnology devices. By enabling the synthesis of long DNA sequences without economic or time constraints, Ribbon Biolabs aims to advance the next wave of biotechnologies and facilitate cutting-edge research in genetic solutions.

Depixus is a biotechnology company that has developed a novel technology designed for real-time analysis of individual biomolecular interactions at a large scale. Its platform enables comprehensive genome analysis, allowing researchers to examine entire genomic regions quickly and efficiently. This integrated system provides the flexibility to specify the desired level of sequence and epigenetic detail, facilitating the discovery of new biological pathways and the decoding of disease mechanisms. By enhancing the understanding of these processes, Depixus aims to contribute to the development of new precision medicines. The company's focus on advanced DNA and RNA sequencing technologies addresses the limitations of current methods, particularly in achieving single-molecule precision.

The Raspberry Pi Foundation is a prominent organization focused on designing and developing high-performance, low-cost single-board computers and compute modules. These products cater to a diverse range of markets, including industrial IoT, education, and hobbyist applications. Known for its credit-card sized computer that connects to televisions and keyboards, Raspberry Pi enables users to perform various tasks, from word processing to playing high-definition video. The foundation operates as a full-stack engineering entity, engaging in extensive research and development efforts either in-house or through strategic partnerships. Its capabilities encompass the entire value chain, from developing semiconductor intellectual property to the design of finished electronic products and software engineering, ensuring a comprehensive approach to meeting the needs of its customers.

Hellsicht develops AI technology solutions for the defence and security sector.

TechMet Limited is a private industrial company based in Dublin, Ireland, established in 2017. It focuses on securing the supply of key technology metals essential for advanced technologies, including electric vehicles, renewable energy systems, and energy storage devices. The company engages in various stages of the metal supply chain, encompassing mining, processing, refining, and recycling. TechMet's portfolio includes interests in production and development assets located in Africa, North America, and South America. By addressing supply chain challenges associated with critical metals such as nickel, cobalt, lithium, rare earth metals, vanadium, tungsten, and tin, TechMet aims to ensure a stable and sustainable supply that supports the growing demand from emerging technologies.

Genomics plc is focused on transforming healthcare through advanced genomic analysis. The company employs sophisticated methodologies to analyze large integrated datasets of genomic and phenotypic information, aiming to enhance understanding of human biology. By leveraging genetic inference technology, Genomics plc seeks to identify new drug targets for serious diseases and assess individual disease risk. Their analytical platform enables the exploration of genomic sequence data, providing valuable insights that support pharmaceutical companies in reducing risks associated with drug development. This approach not only aims to improve healthcare outcomes but also sets a standard for how organizations and patients can benefit from genomic data.

Genomics plc is focused on transforming healthcare through advanced genomic analysis. The company employs sophisticated methodologies to analyze large integrated datasets of genomic and phenotypic information, aiming to enhance understanding of human biology. By leveraging genetic inference technology, Genomics plc seeks to identify new drug targets for serious diseases and assess individual disease risk. Their analytical platform enables the exploration of genomic sequence data, providing valuable insights that support pharmaceutical companies in reducing risks associated with drug development. This approach not only aims to improve healthcare outcomes but also sets a standard for how organizations and patients can benefit from genomic data.

Genomics plc is focused on transforming healthcare through advanced genomic analysis. The company employs sophisticated methodologies to analyze large integrated datasets of genomic and phenotypic information, aiming to enhance understanding of human biology. By leveraging genetic inference technology, Genomics plc seeks to identify new drug targets for serious diseases and assess individual disease risk. Their analytical platform enables the exploration of genomic sequence data, providing valuable insights that support pharmaceutical companies in reducing risks associated with drug development. This approach not only aims to improve healthcare outcomes but also sets a standard for how organizations and patients can benefit from genomic data.

Cambridge Innovation Capital Limited is a venture capital firm based in Cambridge, United Kingdom, that focuses on early-stage, startup, and mid-venture investments in life sciences and technology sectors. Established in 2013, the firm specializes in backing companies affiliated with the University of Cambridge and the surrounding innovation ecosystem. Its investment portfolio includes businesses in therapeutics, medtech, diagnostics, digital health, genomics, proteomics, and high-growth technology sectors such as artificial intelligence and quantum technologies. Cambridge Innovation Capital typically invests up to £19 million in each portfolio company, leveraging its strong connections within the Cambridge Cluster to identify and support disruptive, deep-tech ventures. Since its inception, the firm has raised £275 million to fuel innovation and growth in these high-potential areas.

Drayson Technologies Group operates an Internet of Things (IoT) platform that leverages wireless charging technology and machine learning to develop smart sensor networks. The company's offerings include CleanSpace, an air pollution monitoring platform for enterprises and municipalities; CleanSpace API, a software tool for integrating air pollution data into various applications; and Aura, an end-to-end IoT network for monitoring indoor assets and environmental conditions. Additionally, Drayson Technologies provides SEND for monitoring vital signs in hospital patients, GDm-health for managing diabetes in pregnant women, and EDGE for chronic obstructive pulmonary disease management. Founded in 2015 and headquartered in London, the company has sales hubs in Mexico and San Francisco, focusing on energy-efficient and cost-effective IoT solutions that enhance data collection and analysis while reducing overall operational costs.

BenevolentAI is a clinical-stage company specializing in AI-enabled drug discovery and development. By leveraging its advanced AI platform alongside scientific expertise and laboratory capabilities, the company aims to create novel drug candidates that demonstrate a higher likelihood of clinical success compared to traditional approaches. The Benevolent Platform supports a robust pipeline that includes over 20 drug programs, encompassing all stages from target discovery to clinical studies. Additionally, BenevolentAI collaborates with major pharmaceutical companies and leading research and charitable institutions to enhance its research efforts. The company is headquartered in London, with research facilities in Cambridge and an office in New York.

Spotify Limited is a leading digital music-streaming service that offers users on-demand access to a vast library of songs across various devices, including computers, mobile phones, and home entertainment systems. Founded in 2006 and headquartered in Stockholm, Sweden, Spotify allows users to search for and discover music from friends, artists, and celebrities, while also enabling them to create, share, and edit playlists collaboratively. The platform includes features like personalized recommendations and radio playlists based on users' listening habits. Spotify operates on a freemium model, with revenue generated primarily from its premium subscription service and a secondary ad-supported service. As of 2023, the company boasts 602 million monthly active users, with a significant portion of its revenue derived from subscriptions. Additionally, Spotify provides tools for artists to promote their music through advertising and social media integration.

Genomics plc is focused on transforming healthcare through advanced genomic analysis. The company employs sophisticated methodologies to analyze large integrated datasets of genomic and phenotypic information, aiming to enhance understanding of human biology. By leveraging genetic inference technology, Genomics plc seeks to identify new drug targets for serious diseases and assess individual disease risk. Their analytical platform enables the exploration of genomic sequence data, providing valuable insights that support pharmaceutical companies in reducing risks associated with drug development. This approach not only aims to improve healthcare outcomes but also sets a standard for how organizations and patients can benefit from genomic data.

ACHICA is a members-only luxury lifestyle store based in Cheltenham, United Kingdom. It offers members significant discounts, sometimes up to 70%, on a variety of luxury products including homeware, kitchen items, garden accessories, children's goods, gifts, and clothing, with new brands featured every day for a limited time of 48 hours. Membership is free, and the private sale model ensures that only registered members can access the offerings, protecting the brands promoted on the platform. Co-founded in February 2010 by online retail experts Quentin Griffiths and William Cooper, ACHICA has positioned itself as a unique online retail experience, leveraging their extensive backgrounds in digital marketing and e-commerce to create a distinctive shopping environment.

Aldermore Bank is a UK-based commercial bank established in 2009, specializing in providing straightforward financial products and services primarily to small and medium-sized enterprises (SMEs), homeowners, landlords, and individual clients. The bank focuses on four main lending areas: asset finance, invoice finance, SME commercial mortgages, and residential mortgages. It serves a diverse range of sectors, including automotive, logistics, media, construction, and manufacturing, among others. By offering tailored financial solutions, Aldermore Bank aims to meet the specific needs of its clients, thereby facilitating their growth and financial stability.

Displaydata Ltd. specializes in the design and supply of fully graphic electronic shelf labels (ESLs) and dynamic digital display solutions tailored for omni-channel retailers. The company offers a range of ESLs, including its Chroma and Aura products that utilize electrophoretic display technology for effective in-store product labeling. Its Dynamic Communicator enables secure, two-way data communication between headquarters and store labels, while Dynamic Central provides comprehensive software management for retail operations. Additional offerings include Dynamic Capture for real-time data monitoring, Dynamic Connect for secure store connections, Dynamic Create for label design, and Dynamic Control for on-site management via handheld terminals. Founded in 2000 and based in Bracknell, United Kingdom, with a support center in Atlanta, Displaydata has established itself as a leader in the ESL market, partnering with major retail brands across the US, Europe, Latin America, and Asia to enhance customer experiences and streamline pricing strategies.

Infinity SDC is a prominent UK data centre operator renowned for its strategically located facilities near London. The company specializes in the design, construction, and maintenance of efficient data centres that help clients reduce energy costs and carbon emissions. Infinity offers a comprehensive range of premium services, including shared and bespoke data halls tailored to client needs. Its customer base includes leading investment banks, cloud vendors, systems integrators, and telecommunications companies. Known for its resilience, flexibility, and security, Infinity aims to exceed client expectations both commercially and technically.

Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, that specializes in the development and commercialization of respiratory products. The company operates through three main segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, products designed for asthma diagnosis and management, and offers Tudorza and Duaklir for the treatment of COPD. The latter is a fixed-dose combination inhaler that delivers medication for COPD maintenance. Additionally, Circassia is advancing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly to specialists in several countries, including the United States, United Kingdom, China, Italy, and Germany, as well as through international partners. Circassia has a collaboration with AstraZeneca for the promotion of Tudorza and Duaklir, along with U.S. and Chinese commercial rights to LungFit. Founded in 2006, Circassia Group Plc was formerly known as Circassia Pharmaceuticals plc until its name change in May 2020.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, that specializes in the development and commercialization of respiratory products. The company operates through three main segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, products designed for asthma diagnosis and management, and offers Tudorza and Duaklir for the treatment of COPD. The latter is a fixed-dose combination inhaler that delivers medication for COPD maintenance. Additionally, Circassia is advancing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly to specialists in several countries, including the United States, United Kingdom, China, Italy, and Germany, as well as through international partners. Circassia has a collaboration with AstraZeneca for the promotion of Tudorza and Duaklir, along with U.S. and Chinese commercial rights to LungFit. Founded in 2006, Circassia Group Plc was formerly known as Circassia Pharmaceuticals plc until its name change in May 2020.